PortfoliosLab logoPortfoliosLab logo
OHI vs. BMY
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

OHI vs. BMY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Omega Healthcare Investors, Inc. (OHI) and Bristol-Myers Squibb Company (BMY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, OHI achieves a 6.29% return, which is significantly lower than BMY's 8.27% return. Over the past 10 years, OHI has outperformed BMY with an annualized return of 11.91%, while BMY has yielded a comparatively lower 1.00% annualized return.


OHI

1D
1.08%
1M
-3.30%
YTD
6.29%
6M
7.19%
1Y
31.58%
3Y*
22.48%
5Y*
12.56%
10Y*
11.91%

BMY

1D
0.40%
1M
0.23%
YTD
8.27%
6M
11.43%
1Y
20.57%
3Y*
0.45%
5Y*
0.73%
10Y*
1.00%
*Multi-year figures are annualized to reflect compound growth (CAGR)

OHI vs. BMY - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
OHI
Omega Healthcare Investors, Inc.
6.29%25.52%33.57%19.93%3.50%-12.06%-6.81%29.01%40.06%-4.70%
BMY
Bristol-Myers Squibb Company
8.27%0.11%15.81%-26.14%18.98%2.88%0.41%27.74%-12.90%7.71%

Correlation

The correlation between OHI and BMY is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.14

Correlation (3Y)
Calculated over the trailing 3-year period

0.19

Correlation (5Y)
Calculated over the trailing 5-year period

0.20

Correlation (10Y)
Calculated over the trailing 10-year period

0.19

Correlation (All Time)
Calculated using the full available price history since Aug 7, 1992

0.18

Fundamentals

EPS

OHI:

$2.79

BMY:

$3.57

PE Ratio

OHI:

16.38

BMY:

16.02

PEG Ratio

OHI:

1.53

BMY:

0.91

PS Ratio

OHI:

8.54

BMY:

2.40

Total Revenue (TTM)

OHI:

$1.24B

BMY:

$48.48B

Gross Profit (TTM)

OHI:

$739.29M

BMY:

$33.33B

EBITDA (TTM)

OHI:

$1.21B

BMY:

$13.34B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

OHI vs. BMY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

OHI
OHI Risk / Return Rank: 8383
Overall Rank
OHI Sharpe Ratio Rank: 8585
Sharpe Ratio Rank
OHI Sortino Ratio Rank: 8383
Sortino Ratio Rank
OHI Omega Ratio Rank: 8080
Omega Ratio Rank
OHI Calmar Ratio Rank: 8383
Calmar Ratio Rank
OHI Martin Ratio Rank: 8585
Martin Ratio Rank

BMY
BMY Risk / Return Rank: 6565
Overall Rank
BMY Sharpe Ratio Rank: 6565
Sharpe Ratio Rank
BMY Sortino Ratio Rank: 6161
Sortino Ratio Rank
BMY Omega Ratio Rank: 5858
Omega Ratio Rank
BMY Calmar Ratio Rank: 7171
Calmar Ratio Rank
BMY Martin Ratio Rank: 7070
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

OHI vs. BMY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Omega Healthcare Investors, Inc. (OHI) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


OHIBMYDifference
Sharpe ratioReturn per unit of total volatility

+0.92

Sortino ratioReturn per unit of downside risk

+1.22

Omega ratioGain probability vs. loss probability

1.29

1.14

+0.15

Calmar ratioReturn relative to maximum drawdown

2.92

1.53

+1.39

Martin ratioReturn relative to average drawdown

7.97

3.32

+4.65

OHI vs. BMY - Sharpe Ratio Comparison

The current OHI Sharpe Ratio is 1.60, which is higher than the BMY Sharpe Ratio of 0.68. The chart below compares the historical Sharpe Ratios of OHI and BMY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

OHI vs. BMY - Drawdown Comparison

The maximum OHI drawdown since its inception was -94.85%, which is greater than BMY's maximum drawdown of -72.03%. Use the drawdown chart below to compare losses from any high point for OHI and BMY.


Loading charts...

Drawdown Indicators


OHIBMYDifference

Max Drawdown

Largest peak-to-trough decline

-94.85%

-72.03%

-22.82%

Max Drawdown (1Y)

Largest decline over 1 year

-10.86%

-12.05%

+1.19%

Max Drawdown (3Y)

Largest decline over 3 years

-15.47%

-36.85%

+21.38%

Max Drawdown (5Y)

Largest decline over 5 years

-26.70%

-47.67%

+20.97%

Max Drawdown (10Y)

Largest decline over 10 years

-66.92%

-47.67%

-19.25%

Current Drawdown

Current decline from peak

-6.57%

-17.79%

+11.22%

Average Drawdown

Average peak-to-trough decline

-24.04%

-22.38%

-1.66%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.97%

6.34%

-2.37%

Volatility

OHI vs. BMY - Volatility Comparison

The current volatility for Omega Healthcare Investors, Inc. (OHI) is 7.52%, while Bristol-Myers Squibb Company (BMY) has a volatility of 8.22%. This indicates that OHI experiences smaller price fluctuations and is considered to be less risky than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


OHIBMYDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.52%

8.22%

-0.70%

Volatility (6M)

Calculated over the trailing 6-month period

15.17%

18.18%

-3.01%

Volatility (1Y)

Calculated over the trailing 1-year period

19.86%

27.08%

-7.22%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

24.26%

24.02%

+0.24%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

34.27%

25.29%

+8.98%

Dividends

OHI vs. BMY - Dividend Comparison

OHI's dividend yield for the trailing twelve months is around 5.86%, more than BMY's 4.38% yield.


PositionTTM20252024202320222021202020192018201720162015
BMY
Bristol-Myers Squibb Company
4.38%4.60%4.24%4.44%3.00%2.36%3.69%2.55%3.08%2.55%1.95%2.17%
OHI
Omega Healthcare Investors, Inc.
5.86%6.04%7.08%8.74%9.59%9.06%7.38%6.26%7.51%9.22%7.55%6.23%

Financials

OHI vs. BMY - Financials Comparison

This section allows you to compare key financial metrics between Omega Healthcare Investors, Inc. and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B10.00B12.00B20222023202420252026
322.96M
11.49B
(OHI) Total Revenue
(BMY) Total Revenue
Values in USD except per share items

OHI vs. BMY - Profitability Comparison

The chart below illustrates the profitability comparison between Omega Healthcare Investors, Inc. and Bristol-Myers Squibb Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%100.0%202220232024202520260
70.2%
Portfolio components
OHI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Omega Healthcare Investors, Inc. reported a gross profit of 0.00 and revenue of 322.96M. Therefore, the gross margin over that period was 0.0%.

BMY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported a gross profit of 8.07B and revenue of 11.49B. Therefore, the gross margin over that period was 70.2%.

OHI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Omega Healthcare Investors, Inc. reported an operating income of 0.00 and revenue of 322.96M, resulting in an operating margin of 0.0%.

BMY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported an operating income of 3.27B and revenue of 11.49B, resulting in an operating margin of 28.5%.

OHI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Omega Healthcare Investors, Inc. reported a net income of 165.02M and revenue of 322.96M, resulting in a net margin of 51.1%.

BMY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported a net income of 2.68B and revenue of 11.49B, resulting in a net margin of 23.3%.


Frequently Asked Questions


OHI and BMY have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BMY has higher volatility (8.22%) compared to OHI (7.52%). In terms of maximum drawdown, OHI dropped -94.85% vs BMY's -72.03%.

OHI currently has the higher Sharpe Ratio (1.60 vs 0.68), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for OHI and BMY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer